We are live on ! Find out more
TTNP

Titan Pharmaceuticals
TTNP

Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

20 hedge funds and large institutions have $158K invested in Titan Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

205% more capital invested

Capital invested by funds: $51.9K → $158K (+$106K)

18% more funds holding

Funds holding: 17 → 20 (+3)

2.51% more ownership

Funds ownership: 1.62% → 4.12% (+2.5%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
20
Holders Change
+3
Holders Change %
+17.65%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$48.3K
2
MG
Marex Group
+$45.2K
3
UBS Group
UBS Group
Switzerland
+$3.53K
4
Citadel Advisors
Citadel Advisors
Florida
+$458
5
Raymond James Financial
Raymond James Financial
Florida
+$4

Top Sellers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
-$21
2
Morgan Stanley
Morgan Stanley
New York
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$50.7K +$458 +108 +0.9%
Renaissance Technologies
2
Renaissance Technologies
New York
$47.8K +$48.3K +11,380 New
MG
3
Marex Group
$44.8K +$45.2K +10,663 New
UBS Group
4
UBS Group
Switzerland
$14.4K +$3.53K +833 +32%
CA
5
CoreCap Advisors
Michigan
$370 – – –
Bank of America
6
Bank of America
North Carolina
$75 – – –
Group One Trading
7
Group One Trading
Illinois
$50 – – –
Osaic Holdings
8
Osaic Holdings
Arizona
$40 -$21 -5 -33%
BlackRock
9
BlackRock
New York
$25 – – –
Morgan Stanley
10
Morgan Stanley
New York
$8 -$8 -2 -50%
GWSA
11
Global Wealth Strategies & Associates
Colorado
$8 – – –
CSC
12
Caldwell Sutter Capital
California
$4 – – –
CIA
13
Cape Investment Advisory
Georgia
$4 – – –
DJSG
14
D.J. St. Germain
Massachusetts
$4 – – –
NRG
15
Nemes Rush Group
Michigan
$4 – – –
RA
16
Ransom Advisory
Rhode Island
$4 – – –
SS
17
SBI Securities
Japan
$4 – – –
Wells Fargo
18
Wells Fargo
California
$4 – – –
WIM
19
Westside Investment Management
California
$4 – – –
Raymond James Financial
20
Raymond James Financial
Florida
$4 +$4 +1 New

TTNP Hedge Fund Activity: Q2 2025 in Review

20 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Titan Pharmaceuticals (TTNP) for Q2 2025, worth a combined $158K — up 205% from $51.9K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TTNP positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $48.3K. The largest seller was Osaic Holdings, cutting an estimated $21.

  • 20 institutional investors held Titan Pharmaceuticals (TTNP) as of Q2 2025, up from 17 in Q1 2025.
  • Funds reported $158K of Titan Pharmaceuticals stock for Q2 2025, up 205% quarter-over-quarter.
  • 3 funds opened new Titan Pharmaceuticals positions in Q2 2025 and 0 closed out, a net change of +3 holders.
  • The largest Titan Pharmaceuticals buyer in Q2 2025 was Renaissance Technologies, an estimated $48.3K added.
  • The largest Titan Pharmaceuticals seller in Q2 2025 was Osaic Holdings, an estimated $21 sold.

Based on aggregated 13F filings for Q2 2025.